Bamipine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Protected "Bamipine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(One intermediate revision by one other user not shown) | |||
Line 2: | Line 2: | ||
| verifiedrevid = 437205596 | | verifiedrevid = 437205596 | ||
| IUPAC_name = ''N''-benzyl-1-methyl-''N''-phenyl-piperidin-4-amine | | IUPAC_name = ''N''-benzyl-1-methyl-''N''-phenyl-piperidin-4-amine | ||
| image = Bamipine. | | image = Bamipine.png | ||
<!--Clinical data--> | <!--Clinical data--> |
Latest revision as of 17:55, 18 August 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral, topical |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H24N2 |
Molar mass | 280.407 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Bamipine |
Articles |
---|
Most recent articles on Bamipine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bamipine at Clinical Trials.gov Clinical Trials on Bamipine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bamipine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Bamipine Risk calculators and risk factors for Bamipine
|
Healthcare Provider Resources |
Causes & Risk Factors for Bamipine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bamipine is an antihistamine with anticholinergic properties used as an antipruritic